Search

everythinglearnresearchcommunity

for

Search:↓

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Cetaceans lost hair due to changes in the Hr and FGF5 genes.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Some medications can help increase sexual desire and function in women.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Tamoxifen caused hair loss in a 52-year-old woman.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Breast cancer may be detectable through changes in scalp hair lipids.